Reevaluation of gastroesophageal reflux disease as a risk factor for laryngeal cancer

Laryngoscope

Volumn 121, Issue 1, 2011, Pages 102-105

  Francis, David O ^a   Maynard, Charles ^a,c   Weymuller, Ernest A ^b   Reiber, Gayle ^a,c   Merati, Albert L ^b   Yueh, Bevan ^d  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

extraesophageal reflux; Gastroesophageal reflux disease; laryngeal cancer; Level of Evidence: 3; reverse causality

Indexed keywords

AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE DURATION; GASTROESOPHAGEAL REFLUX; HUMAN; LARYNX CANCER; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; SEX RATIO; SMOKING; STATISTICAL ANALYSIS;

AGED; CASE-CONTROL STUDIES; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 78651088863     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.21165     Document Type: Article

References (27)

1. Chu EA, Kim YJ., Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am 2008; 41: 673-695.
2. Hashibe M, Brennan P, Benhamou S, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 2007; 99: 777-789.
3. Baumann JL, Cohen S, Evjen AN, et al. Human papillomavirus in early laryngeal carcinoma. Laryngoscope 2009; 119: 1531-1537.
4. Abbasi R, Ramroth H, Becher H, Dietz A, Schmezer P, Popanda O., Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int J Cancer 2009; 125: 1431-1439.
5. El-Serag HB, Hepworth EJ, Lee P, Sonnenberg A., Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am J Gastroenterol 2001; 96: 2013-2018.
6. Mercante G, Bacciu A, Ferri T, Bacciu S., Gastroesophageal reflux as a possible co-promoting factor in the development of the squamous-cell carcinoma of the oral cavity, of the larynx and of the pharynx. Acta Otorhinolaryngol Belg 2003; 57: 113-117.
7. Biacabe B, Laccourreye O, Harti DM, Bouchoucha M, Brasnu D., Silent gastroesphageal reflux disease in patients with pharyngolaryngeal cancer: further results. Head Neck 1998; 20: 510-514.
8. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III., Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-1456.
9. Koufman JA., The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991; 101: 1-78.
10. Johnston N, Dettmar PW, Lively MO, et al. Effect of pepsin on laryngeal stress protein (Sep70, Sep53, and Hsp70) response: role in laryngopharyngeal reflux disease. Ann Otol Rhinol Laryngol 2006; 115: 47-58.
11. Samuels TL, Johnston N., Pepsin as a causal agent of inflammation during nonacidic reflux. Otolaryngol Head Neck Surg 2009; 141: 559-563.
12. Adams J, Heintz P, Gross N, et al. Acid/pepsin promotion of carcinogenesis in the hamster cheek pouch. Arch Otolaryngol Head Neck Surg 2000; 126: 405-409.
13. Galli J, Cammarota G, Calo L, et al. The role of acid and alkaline reflux in laryngeal squamous cell carcinoma. Laryngoscope 2002; 112: 1861-1865.
14. Qadeer MA, Colabianchi N, Vaezi MF., Is GERD a risk factor for laryngeal cancer? Laryngoscope 2005; 115: 486-491.
15. Lewin JS, Gillenwater AM, Garrett JD, et al. Characterization of laryngopharyngeal reflux in patients with premalignant or early carcinomas of the larynx. Cancer 2003; 97: 1010-1014.
16. Vaezi MF, Qadeer MA, Lopez R, Colabianchi N., Laryngeal cancer and gastroesophageal reflux disease: a case-control study. Am J Med 2006; 119: 768-776.
17. Chen MY, Ott DJ, Casolo BJ, Moghazy KM, Koufman JA., Correlation of laryngeal and pharyngeal carcinomas and 24-hour pH monitoring of the esophagus and pharynx. Otolaryngol Head Neck Surg 1998; 119: 460-462.
18. Ling ZQ, Mukaisho K, Hidaka M, Chen KH, Yamamoto G, Hattori T., Duodenal contents reflux-induced laryngitis in rats: possible mechanism of enhancement of the causative factors in laryngeal carcinogenesis. Ann Otol Rhinol Laryngol 2007; 116: 471-478.
19. Ozlugedik S, Yorulmaz I, Gokcan K., Is laryngopharyngeal reflux an important risk factor in the development of laryngeal carcinoma? Eur Arch Otorhinolaryngol 2006; 263: 339-343.
20. Wilson JA., What is the evidence that gastroesophageal reflux is involved in the etiology of laryngeal cancer? Curr Opin Otolaryngol Head Neck Surg 2005; 13: 97-100.
21. VIReC Research User Guide: FY2006 VHA Medical SAS Outpatient Datasets. Hines, IL: VA Information Resource Center, 2006.
22. Sherman SE., A framework for tobacco control: lessons learnt from Veterans Health Administration. BMJ 2008; 336: 1016-1019.
23. Salvi SS, Barnes PJ., Chronic obstructive pulmonary disease in non-smokers. Lancet 2009; 374: 733-743.
24. Qadeer MA, Swoger J, Milstein C, et al. Correlation between symptoms and laryngeal signs in laryngopharyngeal reflux. Laryngoscope 2005; 115: 1947-1952.
25. Adhami T, Goldblum JR, Richter JE, Vaezi MF., The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol 2004; 99: 2098-2106.
26. Hamlett-Berry K, Davison J, Kivlahan DR, Matthews MH, Hendrickson JE, Almenoff PL., Evidence-based national initiatives to address tobacco use as a public health priority in the Veterans Health Administration. Mil Med 2009; 174: 29-34.
27. Bradley KA, Williams EC, Achtmeyer CE, et al. Measuring performance of brief alcohol counseling in medical settings: a review of the options and lessons from the Veterans Affairs (VA) health care system. Subst Abus 2007; 28: 133-149.